dc.contributorPrograma de Pós-Graduação em Ciências da Saúde
dc.contributorFaculdade de Medicina
dc.contributorUniversidade do Estado de São Paulo
dc.date.accessioned2022-04-28T19:47:46Z
dc.date.accessioned2022-12-20T01:31:06Z
dc.date.available2022-04-28T19:47:46Z
dc.date.available2022-12-20T01:31:06Z
dc.date.created2022-04-28T19:47:46Z
dc.date.issued2021-01-01
dc.identifierRevista da Sociedade Brasileira de Medicina Tropical, v. 54.
dc.identifier0037-8682
dc.identifierhttp://hdl.handle.net/11449/222960
dc.identifier10.1590/0037-8682-0385-2021
dc.identifier2-s2.0-85120357900
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/5403089
dc.description.abstractThe use of coronavirus disease 2019 RNA vaccines in pregnant women led to reports on the first cases of newborns with antibodies to sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a phenomenon that was unknown when using immunizations with inactivated viruses. Thus, this study aimed to report a case of passive anti-SARS-CoV-2 immunity in a newborn through immunoprophylaxis of a pregnant woman who received the CoronaVac® vaccine in the third trimester of pregnancy. Twenty-four hours after delivery, samples were collected from the newborn and screened by enzyme immunoassays, which revealed antibodies to SARS-CoV-2.
dc.languageeng
dc.relationRevista da Sociedade Brasileira de Medicina Tropical
dc.sourceScopus
dc.subjectCoronavirus infections
dc.subjectImmunization passive
dc.subjectVaccine
dc.titleVertical transmission of maternal covid-19 antibodies after coronavac vaccine: A case report
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución